- Home
- FBYD vs KOD Comparison
FBYD vs KOD Comparison
Compare FBYD & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBYD | KOD |
|---|---|---|
| Founded | 2021 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 821.0M | 1.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | FBYD | KOD |
|---|---|---|
| Price | $12.91 | $27.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | 207.2K | ★ 1.1M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $9,673,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2,743.96 | ★ N/A |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $3.62 | $1.92 |
| 52 Week High | $29.02 | $31.18 |
Technical Indicators
Market Signals| Indicator | FBYD | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 55.54 |
| Support Level | $15.27 | $23.92 |
| Resistance Level | $17.91 | $31.18 |
| Average True Range (ATR) | 2.28 | 2.41 |
| MACD | -0.46 | -0.47 |
| Stochastic Oscillator | 14.08 | 43.32 |
Price Performance
Historical ComparisonAbout FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.